Loading
Globeimmune Inc Stock: price and insider trades · United States
Globeimmune Inc: what insiders have been doing
Globeimmune Inc, founded in 1995, is a Health Care company based in Louisville, United States. Its directors and officers file their transactions with SEC (Form 4). Globeimmune Inc has had no insider filing for more than a year; the last one goes back to 21 March 2016.
The full history, which starts in 2016, counts no purchases against 79 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Xenon Pharmaceuticals Inc. and Vivos Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
79
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€65,105
79 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2015FY ended December 2015 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$5.6M
EBITDA-US$1.9M-35% margin
Net income-US$2.4M-33.3% margin
Valuation
P/Book0.0x
Beta-343.15
Profitability & ownership
ROE-66.2%
ROA-10.3%
% institutions0.0%
Last declaration on 21 March 2016
Declarations79 total
26,188 shares@ US$0.0001100.0% of flowCommon StockSEC:0001209191-16-109755:0
112 shares@ US$1.85Common StockSEC:0001209191-16-109553:1
158 shares@ US$1.52Common StockSEC:0001209191-16-109553:3
8,862 shares@ US$0.00020.0% of flowCommon StockSEC:0001209191-16-109553:0
12,468 shares@ US$0.00010.0% of flowCommon StockSEC:0001209191-16-109553:2
11,000 shares@ US$0.00019.9% of flowCommon StockSEC:0001209191-16-109559:0
2,500 shares@ US$2.05Common StockSEC:0001209191-16-109205:0
2,131 shares@ US$2.32Common StockSEC:0001209191-16-108690:1
645 shares@ US$2.17Common StockSEC:0001209191-16-108690:3
76,662 shares@ US$0.000.0% of flowCommon StockSEC:0001209191-16-108690:0
50,831 shares@ US$0.000.0% of flowCommon StockSEC:0001209191-16-108690:2
200 shares@ US$1.35Common StockSEC:0001209191-16-108196:0
16,300 shares@ US$0.000110.3% of flowCommon StockSEC:0001209191-16-108196:1
159 shares@ US$1.14Common StockSEC:0001209191-16-107676:1
157 shares@ US$1.21Common StockSEC:0001209191-16-107676:3
127 shares@ US$1.16Common StockSEC:0001209191-16-107676:5
5,741 shares@ US$0.00020.0% of flowCommon StockSEC:0001209191-16-107676:0
5,643 shares@ US$0.00020.0% of flowCommon StockSEC:0001209191-16-107676:2
4,573 shares@ US$0.00030.0% of flowCommon StockSEC:0001209191-16-107676:4
5,000 shares@ US$0.00026.9% of flowCommon StockSEC:0001209191-16-107020:0
5,010 shares@ US$0.00026.5% of flowCommon StockSEC:0001209191-16-107020:1
5,000 shares@ US$0.00027.2% of flowCommon StockSEC:0001209191-16-107020:2
1,654 shares@ US$1.12Common StockSEC:0001209191-16-106737:0
46 shares@ US$1.12Common StockSEC:0001209191-16-106737:1
176 shares@ US$1.02Common StockSEC:0001209191-16-106737:3
25 of 79 declarations
About Globeimmune Inc
Globeimmune Inc is a biopharmaceutical company focused on developing immunological treatments for cancer and infectious diseases. The company is listed on NASDAQ.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
